Ali Khademhosseini
Ali Khademhosseini is a prominent Iranian-Canadian bioengineer and scientist known for his significant contributions to the fields of tissue engineering, biomaterials, and regenerative medicine. He is a Professor at the University of California, Los Angeles (UCLA) and the Director of the Center for Minimally Invasive Therapeutics (C-MIT).
Early Life and Education[edit | edit source]
Ali Khademhosseini was born in Tehran, Iran. He moved to Canada at a young age and pursued his higher education there. He received his B.Sc. in Chemical Engineering from the University of Toronto. He then went on to earn his Ph.D. in Bioengineering from the Massachusetts Institute of Technology (MIT) under the supervision of Robert Langer.
Career[edit | edit source]
After completing his Ph.D., Khademhosseini joined the faculty at Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology. He later moved to UCLA, where he has continued his groundbreaking research.
Research[edit | edit source]
Khademhosseini's research focuses on developing innovative biomaterials and microfabrication techniques for tissue engineering and regenerative medicine. His work has led to advancements in the creation of hydrogels, microscale technologies, and organ-on-a-chip systems. These technologies have potential applications in drug delivery, disease modeling, and the development of artificial organs.
Publications and Patents[edit | edit source]
Khademhosseini has authored over 500 peer-reviewed articles and holds numerous patents in the field of bioengineering. His work is highly cited, and he is considered one of the leading researchers in his field.
Awards and Honors[edit | edit source]
Throughout his career, Khademhosseini has received numerous awards and honors, including the Pioneers of Miniaturization Prize, the Clemson Award from the Society For Biomaterials, and the Young Investigator Award from the Controlled Release Society.
Personal Life[edit | edit source]
Khademhosseini is married and has children. He is known for his dedication to mentoring young scientists and fostering interdisciplinary collaboration.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
